News

Timber (TMBR) to Get Acquired by LEO Pharma for $36M, Stock Up

  • Timber (TMBR) surges as LEO Pharma offers to acquire it for approximately $36 million.
    08/22/2023

Why Is Timber Pharmaceuticals (TMBR) Stock Up 96% Today?

  • Timber Pharmaceuticals (NYSEMKT: TMBR ) stock is undergoing a massive rally on Monday after announcing that Leo US is acquiring it in a $36 million deal. According to a press release from Timber Pharmaceuticals, that acquisition has an upfront payment of $14 million for TMBR stock.
    08/21/2023
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

Timber Pharmaceuticals, Inc. (TMBR) can hold. Click on Rating Page for detail.

The price of Timber Pharmaceuticals, Inc. (TMBR) is 0.3426 and it was updated on 2024-04-25 07:01:46.

Currently Timber Pharmaceuticals, Inc. (TMBR) is in undervalued.

News
    
News

Timber (TMBR) Surges on Carcinogenicity Waiver for TMB-001

  • Timber (TMBR) receives a dermal carcinogenicity waiver from the FDA for TMB-001, which is being developed to treat moderate-to-severe subtypes of congenital ichthyosis.
    Thu, Jun. 08, 2023

Bears are Losing Control Over Timber Pharmaceuticals, Inc. (TMBR), Here's Why It's a 'Buy' Now

  • Timber Pharmaceuticals, Inc. (TMBR) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
    Fri, Apr. 14, 2023

Building a Penny Stocks Portfolio For Long Term

  • Use these tips for buying penny stocks for the long term The post Building a Penny Stocks Portfolio For Long Term  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
    Mon, Feb. 27, 2023

Penny Stock Investing: How to Analyze Market Conditions

  • Use these tips to analyze penny stocks The post Penny Stock Investing: How to Analyze Market Conditions appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
    Sun, Feb. 26, 2023

Why Is Timber Pharmaceuticals (TMBR) Stock Up 61% Today?

  • Timber Pharmaceuticals (NYSEMKT: TMBR ) stock is taking off on Friday after getting an orphan drug designation in Europe. That comes from the EC and covers TMB-001 for the treatment of X-linked recessive ichthyosis.
    Fri, Feb. 24, 2023
SEC Filings
SEC Filings
Press Releases
StockPrice Release
More Headlines
News

Top Penny Stocks To Buy? 4 For Your Watch List Before Next Week

  • Penny stocks under $1 to watch this week. The post Top Penny Stocks To Buy?
  • 08/25/2022

Best Penny Stocks to Buy Now? 3 For Your August List

  • Here's what you need to know about trading penny stocks on August 10th The post Best Penny Stocks to Buy Now? 3 For Your August List appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
  • 08/10/2022

Best Penny Stocks to Buy Under $1? 3 to Watch as April Ends

  • Are these under $1 penny stocks on your watchlist? The post Best Penny Stocks to Buy Under $1?
  • 04/28/2022

Timber Pharmaceuticals to Present at H.C. Wainwright BioConnect Conference

  • Virtual Conference on January 10-13, 2022
  • 01/06/2022

Timber Pharmaceuticals to Host Conference Call Discussing Positive Topline Results from Phase 2b CONTROL Study of Congenital Ichthyosis for Lead Asset, TMB-001

  • Call to be held on Monday, November 22nd at 10:00am ET
  • 11/17/2021

TMBR Stock: Why The Price Plummeted Today

  • The stock price of Timber Pharmaceuticals Inc (NYSEAMERICAN: TMBR) fell by over 33% during intraday trading today. This is why it happened.
  • 11/03/2021

Timber Pharmaceuticals Reports Positive Top-line Results from Phase 2b CONTROL Study Evaluating TMB-001 in Moderate to Severe Congenital Ichthyosis

  • Basking Ridge, NJ, Oct. 07, 2021 (GLOBE NEWSWIRE) -- via  NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced positive top-line data from its Phase 2b CONTROL study evaluating TMB-001, an investigational topical isotretinoin formulated using Timber's patented IPEG™ delivery system, in patients with moderate to severe congenital ichthyosis (CI).
  • 10/07/2021

Timber Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

  • BASKING RIDGE, NJ, Sept. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that it will present at the H.C. Wainwright 23rd Annual Global Investment Conference. The Conference will be held virtually with all participants joining remotely from September 13th - 15th, 2021.
  • 09/10/2021

Timber Pharmaceuticals Announces Last Patient Last Visit in Phase 2b CONTROL Study Evaluating TMB-001 in Moderate to Severe Congenital Ichthyosis

  • - Topline results expected to be announced in the fourth quarter of 2021 -
  • 08/24/2021

Best Penny Stocks to Buy Now? 3 to Watch This Week

  • Are these top penny stocks worth watching right now? The post Best Penny Stocks to Buy Now?
  • 08/22/2021

7 Hottest Penny Stocks to Pick Up Now

  • Penny stocks from companies that have reasonable business fundamentals. Stocks that can possibly provide multi-fold returns.
  • 08/10/2021

7 Reddit Penny Stocks to Watch for Big Upside Ahead

  • If we've learned anything from the Reddit in January, it's not to underestimate them. These 7 Reddit penny stocks have good upsides.
  • 06/28/2021

Timber Pharmaceuticals Announces Adjournment of Annual Meeting

  • Basking Ridge, NJ, June 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that on June 3, 2021 its 2021 Annual Meeting of Stockholders (the “Annual Meeting”) was convened without a quorum. As a result, in order to provide stockholders additional time within which to vote their eligible shares to establish a quorum, the Annual Meeting was adjourned.
  • 06/03/2021

Timber Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2b CONTROL Study Evaluating TMB-001 in Congenital Ichthyosis

  • - Company plans to ask for end-of-Phase 2 meeting with FDA by end of 2021 -
  • 05/26/2021

Investing in Penny Stocks? Don't Before You Do These 3 Things

  • Before investing in penny stocks, take a look at these 3 things The post Investing in Penny Stocks? Don't Before You Do These 3 Things appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
  • 05/11/2021

Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2021 Financial Results

  • BASKING RIDGE, NJ, May 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today provided a business update and announced financial results for the first quarter ended March 31, 2021.
  • 05/11/2021

7 Reddit Penny Stocks to Buy for a Biotech Boom

  • So, which biotech penny stocks, popular with the Reddit set, offer such opportunity? Consider these seven as ones with potential to live up to online enthusiasm.
  • 04/16/2021

5 Reddit Penny Stocks Seeing the Most Chatter Thursday

  • It's never a dull day on the Reddit Penny Stocks subreddit and we're checking in to see what's being talked about the most today. The post 5 Reddit Penny Stocks Seeing the Most Chatter Thursday appeared first on InvestorPlace.
  • 04/15/2021

DISCB and 6 Other Reddit Stocks Waiting for a Short Squeeze

  • Reddit stocks continue to have the public's attention. These 7 could be the next short squeeze targets based on technical signs.
  • 04/07/2021

Timber Pharmaceuticals Sets Record Date for Annual Meeting of Shareholders and Provides Update on Its Annual Filings

  • Basking Ridge, NJ, April 02, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. (NYSE American: TMBR) ("Timber” or the "Company"), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that its Annual Meeting of Shareholders will be held at 1:00 pm EDT on Thursday, June 3, 2021 (the “Annual Meeting”).  The Company has established April 12, 2021 as the record date for the Annual Meeting.
  • 04/02/2021

Timber Pharmaceuticals Provides Business Update and Announces Year End 2020 Financial Results

  • 50% of patients in the Phase 2b CONTROL study have now been randomized despite COVID-19 disruptions in the trial marketplace
  • 03/23/2021

Timber Pharmaceuticals' Development Partner, AFT Pharmaceuticals, Enters into Licensing Agreement for Pascomer® (TMB-002) in Europe

  • - Extension of agreement with AFT Pharmaceuticals grants Desitin Arzneimittel GmbH exclusive license and supply rights for TMB-002 in Europe -
  • 03/17/2021

Timber Pharmaceuticals Announces 50% Enrollment in Phase 2b CONTROL Study in Congenital Ichthyosis

  • - Study is Evaluating TMB-001 (Topical Isotretinoin) in Subtypes of Rare Genetic Keratinization Disorder
  • 03/15/2021

TMBR Stock Price Increased 71.14%: What You Should Know About The Company

  • The stock price of Timber Pharmaceuticals Inc (NYSEAMERICAN: TMBR) increased by 71.14% today. This is what you should know about the company.
  • 03/11/2021

TMBR Stock: What to Know About Red-Hot Timber Pharmaceuticals

  • Timber Pharmaceuticals spiked more than 75% in trading today following a virtual life sciences conference this week. Trading volume in TMBR stock was up more than 1600% on the day.
  • 03/11/2021

Timber Pharmaceuticals Announces Presentation at 2021 H.C. Wainwright Global Life Sciences Conference

  • WOODCLIFF LAKE, N.J., March 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that Timber's Chief Executive Officer John Koconis will present a corporate overview at the virtual 2021 H.C. Wainwright Global Life Sciences Conference being held on March 9-10, 2021.
  • 03/05/2021

7 Penny Stocks In a Make-or-Break Year

  • These penny stocks are companies that have a crucial year ahead in terms of industry turnaround or company specific product development. The post 7 Penny Stocks In a Make-or-Break Year appeared first on InvestorPlace.
  • 02/24/2021

Timber Pharmaceuticals Appoints Alan Mendelsohn, M.D., as Chief Medical Officer

  • Dr. Mendelsohn has 20+ Years' Experience in Clinical Development and Medical Affairs
  • 01/25/2021

Timber Pharmaceuticals Receives Orphan Drug Designation from U.S. FDA for TMB-003 for the Treatment of Systemic Sclerosis

  • Timber Expects to Submit Investigational New Drug (IND) Application to the FDA in 2022
  • 01/12/2021

Timber Pharmaceuticals Hosts Business Update Conference Call

  • Call to be held on Thursday, December 17th at 11:00am EST
  • 12/10/2020
Unlock
TMBR Ratings Summary
TMBR Quant Ranking